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Abstract
Epidemiological and experimental studies have and continue to offer valuable 
insight into the Developmental Origins of Health and Disease (DOHaD) hypothesis, 
which emphasizes the importance of early-life nutritional and environmental changes 
on the increased risk of metabolic diseases in later life. It is now known that non-com-
municable chronic diseases that were previously associated with lifestyle and genetics 
have their origins early in life. It is well established that early life environmental 
signals, including nutrition, set the stage for long-term health and disease risk—effects 
that span multiple generations. This relationship began still in the intrauterine period 
and extends throughout the critical period of development. Many types of nutritional 
challenges including caloric restriction, macronutrient excess, and micronutrient 
insufficiencies have been shown to induce early life adaptations that produce long-
term dysfunction. Several pathways have been suggested to underpin these associa-
tions, including epigenetic reprogramming of germ cells. While the mechanisms still 
remain to be fully investigated, the relationship of nutrition factors in early life and 
metabolic diseases are clear. This chapter focuses on the role that the nutrition presents 
during critical periods of development and its repercussions into adulthood.
Keywords: metabolic programming, nutrition, epigenetics, developmental 
programming, obesity, microbiome
1. Introduction
In the development period, the fetus may be exposed to an altered risk of devel-
oping diseases in adulthood. In this regard, the hypothesis called Developmental 
Origins of Health and Disease (DOHaD) highlights the relationship between stimuli 
in the early stages of life and the subsequent development of the disease [1–3]. This 
model studies the adaptations that occur in the fetus in response to the intrauterine 
environment, leading to a permanent set of homeostatic systems to assist in imme-
diate survival and improve success in an adverse postnatal environment. However, 
inappropriate interpretations or environmental changes can lead to an incompat-
ibility between prenatal predictions and postnatal reality [4, 5].
Thus, these adaptations known as predictive adaptive responses can be dis-
advantageous in adulthood, resulting in an increased risk of diseases that can be 
transmitted to future generations. In this perspective, it was established that some 
nutritional changes early in life can lead to an increased risk for several diseases in 
adulthood [6, 7].
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Various studies have shown an association between maternal malnutrition and 
exposure to hormones during critical periods of development, with metabolic 
changes, with an emphasis on chronic non-communicable diseases, thyroid dis-
orders, among others [8, 9]. The mother’s malnutrition characteristic is capable of 
interfering with the nutritional status of adult offspring. Maternal protein restric-
tion during lactation led to low weight of the offspring at weaning. Caloric restric-
tion resulted in greater weight gain and resistance to leptin in adult offspring [10].
Programming at a critical stage of development can lead to changes in tissues 
and organs, which extend throughout life; it may also present a latency period 
and manifest only in adult life. More studies are emerging to explain the possible 
mechanisms related to metabolic programming [11, 12].
The mechanisms involved are not entirely clear, but it is believed that there is a 
relationship between changes in the structural development of the organs and with 
persistent changes at the cellular level [13]:
• performance in epigenetic memory, with changes in the transcription process;
• alteration of the organ structure in vascularization, innervation, and juxtapo-
sition, such as the position of hepatocytes, endothelial cells, and Kupffer cells, 
which during organogenesis can permanently modify metabolism;
• hyperplasia or hypertrophy;
• abnormal cell growth under specific metabolic conditions; and
• Metabolic differentiation process.
Molecular mechanisms suggested include acute or chronic changes in gene 
expression, through various avenues, where there is an epigenetic interrelation 
between certain genes, exposure to environmental factors, and biological events [5]. 
Figure 1. 
A complex network that affects adult health and disease, including hormonal and nutrition alterations, 
epigenetic modifications, microbiota, and the exposure to endocrine disruptors.
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As the epigenetic regulation during development changes, the dynamic epigenome 
has an unstable nature, providing a response and adaptation to environmental 
pressures, including nutritional changes [2]. Figure 1 presents the principal mecha-
nisms linked to developmental programming.
There is still a lot to be understood, although epigenetics helps to reveal how 
exposure to environmental factors, in critical periods of development, leads to 
changes in adult life, it is necessary to understand the post-epigenetic changes 
involved in the various processes that lead to the emergence of diseases [13].
2. The early-life origins of obesity
Obesity is defined by an excess of adipose tissue and occurs when an imbalance 
in the balance of energy exists [14]. The origin of obesity is a complex process that 
involves genetic and environmental factors and is often associated with the devel-
opment of chronic complications, such as hyperglycemia, hypertriglyceridemia, 
low HDL levels, and hypertension. Individuals who have at least three of these 
criteria are clinically diagnosed as having metabolic syndrome, which increases the 
risk of developing metabolic diseases, such as type 2 diabetes and cardiovascular 
diseases [15, 16].
In 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of 
these, over 650 million were obese; 41 million children under the age of 5 were over-
weight or obese, as well as over 340 million children and adolescents aged 5–19 [14]. 
Recognizing its etiology is essential to face the global epidemic. This creates a 
challenge since the pathway to obesity in many individuals begins before birth; a 
predisposition to obesity can occur through epigenetic and other forms of early 
programming, and obesity and its metabolic consequences result from physiological 
changes set during fetal and early postnatal development [17–19].
It is known that a number of factors, including epigenetic signals, mitochon-
drial inheritance, milk composition, gut microbiota, and features of the maternal 
metabolic environment, such as insulin resistance, fatty acids, and inflammation, 
may cause developmental programming. In many cases, the effects of the prenatal 
perturbations are exacerbated by postnatal exposure to a high-calorie diet, acceler-
ated postnatal growth, stress, or other factors [20–22].
The early-life origins of obesity are supported by a number of studies, which 
have shown that being exposed to inappropriately nutrition levels during critical 
periods of development (fetal and postnatal) is associated with increased risk of 
obesity, insulin resistance, and type 2 diabetes in child and adult life [23, 24]. The 
excessive or deficient nutritional status before birth alters the development of the 
fat cell, the adipocyte, and results in a permanent increase in the capacity to form 
new cells in adipose depots (adipogenesis) or to store lipid in existing adipocytes 
(lipogenesis) since the adipogenesis occurs primarily during late fetal and early 
postnatal life, and is highly sensitive to the nutritional environment at this time, in 
particular to the prevailing concentrations of insulin-like growth factors, glucose, 
insulin, and glucocorticoids [17, 25].
In addition, there are animal and human data that show that obese mothers are 
more likely to generate to an overweight baby and that these infants are at greater 
risk of obesity in later life. This “intergenerational cycle of obesity” already is a 
well-defined phenomenon, showing that maternal obesity, maternal diabetes, and 
an increase in nutrient supply to the developing fetus constitute major risk factors 
for obesity in postnatal life [26–28].
There is a greater propensity to develop altered energy metabolism in adult 
life, in particular, overweight and/or hyperphagia, after malnutrition during fetal 
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development. This predisposition to develop obesity is particularly clear in the off-
spring of calorie-restricted dams and is also exacerbated when animals are exposed 
to an obesogenic environment in adulthood. Mechanisms contained in the deregula-
tion of food intake and energy balance, due to perinatal nutrition, could be related 
to hypothalamic alterations and a lower capacity to respond to insulin and leptin 
signaling [29]. One potential mechanism of developmental programming is through 
permanent structural alterations of different organs. Different stress exposures 
(oxidative, immune, and inflammatory stresses, as well as maternal-placental-fetal 
endocrine disturbances) during the prenatal development could reprogram the 
telomere biology system [30, 31].
3. Metabolic pathways and epigenetics
During their lifetime, cells receive several external signals, like hormones, 
growth factors, cytokines, and other extracellular factors. This flow of metabo-
lites, through complex metabolic networks, acts optimizing diverse epigenetic 
cofactors, thus relating nutrition and diet changes into cytoplasmic signaling and 
chromatin remodeling. Histone modifications—as DNA methylation, RNA interfer-
ence, and non-coding RNA—inserted by the term epigenetics represent diverted 
ways by which cells control the expression of genes without any alteration in the 
underlying genetic material [32].
The produced metabolites remain the same for a given cell, but tissue function 
and nutrient availability will determine the metabolite requirements. In addition, 
metabolic challenges, such as calorie or oxygen restriction or even a high-fat diet, 
drive decisions about cell fate. Consistently, dramatic epigenetic changes have 
been associated with metabolic disorders, such as obesity, insulin resistance, type 2 
diabetes, and cancer [32, 33].
The changes on the cellular and tissue level are followed by alterations in epi-
genetic regulation of gene expression. Epigenetic modifications refer to heritable 
changes in gene expression occurring without changes in DNA sequence. The 
epigenetic code is changed dramatically in the course of embryonic development 
to initiate varying patterns of gene expression in different developing tissues. 
This code consists of modifications of chromatin histones and DNA playing a 
central role in packing DNA by forming nucleosomes. Mechanisms of epigenetic 
regulation are DNA methylation at cytosine residues in promoter or enhancer gene 
regions, intragenic DNA methylation usually leading to transcriptional silencing, 
and posttranslational modifications of core histone proteins, such as acetylation 
usually resulting in transcriptional activation. Non-coding microRNAs which can 
govern gene activity at both transcriptional and posttranscriptional levels are one 
more recently discovered key component of epigenetic control. Another important 
factor is the microRNA expression that may be modulated by histone modifications 
or DNA methylation and vice versa, thereby causing feedback loops in epigenetic 
regulation [30, 34, 35].
The ability of the genotype to produce different phenotypes in response to dif-
ferent environments is termed “plasticity.” The time of maximal plasticity appears 
to be during development. Nonetheless, heritable phenotypic variation at a later 
stage is also possible because of the individual’s capability to respond to environ-
mental conditions. Plasticity in developmental programming has evolved to provide 
the best chances of survival and reproductive success to the organism. When 
reflecting this theory to developmental data, adaptive growth and metabolic-related 
strategies for transition from one life history phase to the next and the timing of 
such transitions (inherent adaptive plasticity) have evolved [36, 37].
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Adaptive plasticity enables a species to respond to an environmental change to sur-
vive and reproduce and may manifest itself as polyphenism or as a continuous varia-
tion in traits. In evolutionary terms, plastic and developmental responses in early life 
enable an organism to adjust its phenotype so that it can survive in the environment in 
which it will grow and reproduce. However, the adaptation is not always positive, and 
the outcome may be harmful and may result in teratogenesis, diseases, or death [36].
There are two types of adaptive responses (plasticity). The first type is the antic-
ipatory or predictive adaptive responses, where the developing organism forecasts 
the future environment and then adjusts its phenotypic trajectory accordingly. The 
second type is the immediate adaptive responses that promote short-term maternal 
or fetal survival with some advantages in later life (developmental plasticity). These 
adaptive responses have a significant cost, and a cost-benefit analysis is performed 
to determine the true value of the adaptive response. The links between epigenetics, 
developmental programming, and plasticity in early growth and nutrition provide 
subsidies to understand aspects involved in child growth and development and their 
long-term impact [7, 36].
The nutrition is one of the most studied environmental epigenetic factors, and 
already associations have been observed between adverse prenatal nutritional con-
ditions, postnatal health, and increased risk of disease. It is known that maternal 
and paternal diets influence metabolic phenotypes in offspring through epigenetic 
information transmission. Over molecular mechanisms with respect to the fetal 
origins of adult disease have been suggested including mitochondrial dysfunction 
and oxidative stress as among the earliest events described in offspring exposed to 
nutrient restriction. This in turn modifies the expression of critical genes and can 
affect health and longevity [38].
The foods contain nutrients and bioactive components that can modify epi-
genetic marks and alter the expression of genes. These compounds, including 
folate, vitamin B12, methionine, among others, can affect DNA methylation and 
histone, altering 1-carbon metabolism. The S-adenosylmethionine (AdoMet) and 
S-adenosylhomocysteine (AdoHcy), metabolites of 1-carbon metabolism, can alter 
the methylation of DNA and histones. Thus, nutrients and bioactive components, 
as well as conditions that may affect the levels of AdoMet or AdoHcy in the tissue, 
have the ability to modify the methylation of DNA and histones [11, 39].
In a study developed by our research group, we identified that the maternal 
intake of soybeans in lactation changed the lipid content of breast milk and pro-
grammed offspring for a phenotype of the lower metabolic risk. The difference in 
fat content of breast milk and the higher isoflavones content of soy diet are pos-
sible imprinting factors that could program the offspring [18]. This is particularly 
important because it highlights the dual role of nutritional alterations, whether as 
reprogramming strategies to prevent disease or leading to adult disease [40].
The metabolic mechanism linked to the programming induced by the adverse 
intrauterine environment is not completely clear, but fetal metabolic programming 
has already been indicated to contribute to changes in tissue development, number 
of cells, neural circuits, and so on. Epigenetic programming plays an important 
role in the differentiation and development of embryonic, tissue, and stem cells. 
The changes induced by epigenetic modification in cell or tissue function can be 
transmitted from fetuses to adults and induce the development of the metabolic 
syndrome in adult offspring. There is a vulnerable “window” for epigenetic pro-
gramming when germ cells, embryos, and fetuses are in development [11, 41].
Figure 2 presents a scheme of developmental origins of health and disease. 
Epigenetic marks can be modulated by environmental factors, are heritable, per-
petuate gene-expression changes that underlie programming, and may contribute to 
the onset of disease/health in later life.
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4. Microbiome and metabolic health
The genetic set of the microbiome provides extensive metabolic and immuno-
logical potential. Genetic and environmental factors influence microbiota com-
position and function, and these complex host-microbe interactions contribute to 
health and disease state. The gut microorganisms have a significant role in epithelial 
barrier function, fermentation of dietary fiber, synthesis of vitamins, regulation 
of the immune system, and defense against pathogens. This community has also 
been found to play some important roles in angiogenesis, brain development, and 
behavior [15, 42].
Given the various functions of microbiota, alterations in this community 
(dysbiosis) have been associated with a range of non-communicable diseases, 
including obesity, diabetes, inflammatory bowel disease, metabolic syndrome, 
cancer, asthma, allergy, non-alcoholic fatty liver disease (NAFLD), and even certain 
neuropsychiatric disorders [43–46].
The early-life microbiota presents a unique microbial communities consisting 
of numerous bacteria and viruses. A part of this microbiota already has identified 
by using different kinds of technologies including 16S rRNA sequencing. Over the 
last decades, the paradigm of a sterile condition in utero is shifting to the possibility 
of the prenatal maternal-fetal coexist with commensal and symbiotic microbes. 
Recent studies also support a prenatal microbial milieu through bacterial presenta-
tion in placenta, amniotic fluid, umbilical cord, and meconium. In addition, there 
are emerging reports of the prenatal microbial composition on fetal and postnatal 
development [47–49].
A maternal condition during pregnancy and postnatal period can provide a criti-
cal window for susceptibility to microbiome development through environmental 
factors such as mode of delivery and maternal diet. The delivery mode has a crucial 
function in the early gut microbiota composition. Infants by vaginally delivery have 
higher levels of intestinal Bacteroides, Lactobacilli, and Bifidobacterium, which are 
commonly present in vaginal route, whereas infants by cesarean section (C-section) 
have higher level of Enterococcus, and Clostridium from skin, oral, or hospital 
environment [47, 50].
The gestational age is another important influencer for gut microbiome 
development. It is reported that the gut microbiota of preterm infants has shown 
delayed colonization by limited microbial diversity and this risk of gut dysbiosis. 
Figure 2. 
Scheme demonstrative of developmental origins of health and disease, during prenatal and early postnatal life, 
involved in the susceptibility to obesity and metabolic changes.
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The gut microbiota composition of preterm infants has Enterobacter, Enterococcus, 
Escherichia, and Klebsiella predominantly and relatively low level of gammaproteo-
bacteria than those in full-term infants [51, 52].
It is known that breastfeeding influences the infant microbiota. The microbiome 
may affect the DNA methylation through breast milk, which influences the gut 
microbiome composition. Breastfeeding is associated with greater Bacteroides and 
Bifidobacterium, which are folate producers, thereby affecting DNA methylation. 
Breast milk oligosaccharides alter core microbiome community that secretes short-
chain fatty acid (SCFA). Therefore, the strain of Bifidobacterium and Lactobacillus by 
breastfeeding could make intestinal contents more acidic with SCFA, which modu-
late a defense mechanism against pathogens and have epigenetic effects [53–55].
The microbial metabolites such as B vitamins, short-chain fatty acids, polyphe-
nols, and omega 3 polyunsaturated fatty acids are reported to influence epigenetic 
mechanisms. Maternal gut microbe metabolites can change the host cellular levels 
of important epigenetic modifiers like histone acetyl transferases (HATs), histone 
deacetylases (HDACs), DNA methyltransferases (DNMTs), and DNA demethylases. 
The microbial SCFAs from the fermentation of dietary fiber were shown to maintain 
the nervous and immune systems through epigenetic modification. These, acetate 
and butyrate are the most abundant in the intestinal tract and can be produced with 
acetyl-CoA which is universal acetyl group donor for histone acetylation [45, 47].
Different essential functions for human health develop correspondingly with 
gut microorganism increase, including vitamin biosynthesis, energy extraction 
from the diet, gut barrier function, and immune system maturation. The immune 
system of neonates is immature and requires the exposure of gut bacteria to develop 
properly. Depending on the health of the mother, maternal bacterial communities 
may already be imbalanced when passed on to the infant. In children, metabolic 
diseases, including obesity, insulin resistance, and NAFLD, along with other related 
immune-based diseases, are associated with modifications in infant gut bacterial 
composition; however, the mechanisms involved are not entirely clear [43, 56].
5. Conclusions
It is known that there is a close relationship between maternal obesity, diet 
consumption during pregnancy and lactation, and their impact on the microbiota 
of both mother and infant, including their links to early gut colonization and innate 
immunity in the infants that drive an increased risk for metabolic diseases.
For the most effective confrontation of metabolic diseases, which represent a 
great burden of global health, it is important to consider the issues involving early 
nutrition, metabolic programming, and epigenetics. Thus, the adoption of health 
policies during critical stages of development, including pregnancy, lactation, and 
puberty, is essential to achieve long-term consistent results.
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